Treatment of obesity: An overview

Diabetes/Metabolism Reviews

Volumn 4, Issue 7, 1988, Pages 653-679

  Bray, G A ^a   Gray, D S ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEPRAMONE; AMPHETAMINE DERIVATIVE; BENZOCAINE; BENZPHETAMINE; CHLORPHENTERMINE; CHORIONIC GONADOTROPIN; CLORTERMINE; EPHEDRINE; FENFLURAMINE; FLUOXETINE; MAZINDOL; METHYLCELLULOSE; NALOXONE; NEOMYCIN; PHENMETRAZINE; PHENYLPROPANOLAMINE; PHENYTOIN; SEROTONIN DERIVATIVE; THYROID HORMONE;

BEHAVIOR; CALORIC RESTRICTION; CONTROLLED STUDY; DIET; EXERCISE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; OBESITY; PSYCHOLOGICAL ASPECT; REVIEW; THERMOGENESIS;

APPETITE DEPRESSANTS; BEHAVIOR THERAPY; DIET, REDUCING; EXERCISE; HUMAN; OBESITY; RISK FACTORS;

EID: 0023723599     PISSN: 07424221     EISSN: 10990895     Source Type: Journal    
DOI: 10.1002/dmr.5610040704     Document Type: Article

References (117)

1. Understanding and preventing relapses
2. Complications of obesity
3. Calories do count
4. The obese patient
5. Triidothyronine and mercurial diuretics. Effects on excretion of a water load and on plasma free fatty acids in obese patients
6. Dietary‐induced alterations in thyroid hormone metabolism during overnutrition
7. Protein requirements with very low calorie diets
8. Lean body mass‐body fat interrelationships in humans
9. Observations on obese patients eating isocaloric reducing diets with varying proportions of carbohydrate
10. The frequency of meals: Its relationship to overweight, hypercholesterolemia, and decreased glucose‐tolerance
11. Lipogenesis in human adipose tissue: Some effects of nibbling and gorging
12. Long‐term measurements of energy expenditure in humans using a respiration chamber
13. Sudden death associated with very low calorie weight reduction regimes
14. Vigorous supplementation of a hypocaloric diet prevents cardiac arrhythmias and mineral depletion
15. Very‐low‐calorie diets: Their efficacy, safety, and future
16. Starvation and semistarvation diets in the management of obesity
17. The control of eating
18. A three‐dimensional program for the treatment of obesity
19. Advances in behavioral treatment of obesity
20. Treatment of obesity: Comparison of physician and nonphysician therapists using placebo and anorectic drugs in a double‐blind trial
21. Patterns of weight change: The interval 6 to 10 years after initial weight loss in a cognitive‐behavioral treatment program
22. Work‐site treatment for obesity
23. Self‐help weight control groups: A professional and a consumer perspective
24. High attrition rates in commercial weight reduction programs
25. Effectiveness of a self‐help group in obesity control: A further assessment
26. A survey of three slimming and weight control organisations in the U.K.
27. Obesity and psychoanalysis
28. Energy expenditure in small children of obese and non‐obese parents
29. Caloric intake and expenditure of obese boys
30. Evaluation and modification of exercise patterns in the natural environment
31. Body composition in sport and exercise: Directions for future research
32. Effects of physical conditioning on cardiorespiratory function, body composition and serum lipids in relatively normal‐weight and obese middle‐aged women
33. Body composition, physical work capacity and physical activity habits at 18‐month follow‐up of middle‐aged women participating in an exercise intervention program
34. Physical training in human obesity. III. Effects of long‐term physical training on body composition
35. Results of conservative therapy of obesity: Correlation with adipose tissue morphology
36. Effects of long‐term physical training on body fat, metabolism, and blood pressure in obesity
37. Treatment of obese schoolchildren
38. Changes in plasma lipid and lipoprotein levels in men and women after a program of moderate exercise
39. Effects of a vigorous walking program on body composition, and carbohydrate and lipid metabolism of obese young men
40. Regulation of energy balance
41. Exercise and weight reduction in obesity
42. The effect of addition of exercise to a regime of dietary restriction on weight loss, nitrogen balance, resting metabolic rate and spontaneous physical activity in three obese women in a metabolic ward
43. Effect of exercise alone on the weight of obese women
44. Effect of diet and/or exercise on obese college women
45. Self‐directed weight control through eating and exercise
46. Behavior modification for obesity: The evaluations of exercise, contingency management, and program adherence
47. Obesity and the unbalanced energy equation: Exercise versus eating habit change
48. Caloric restriction and/or mild exercise: Effects on serum lipids and body composition
49. Effects of dieting and exercise on lean body mass, oxygen uptake, and strength
50. Physical training of obese middle‐aged persons
51. Growth rebound after termination of stimulant drugs
52. Current status of drug therapy in obesity
53. Review of amphetamine‐like drugs by the Food and Drug Administration: Clinical data and value judgments
54. Pharmacological treatment of obesity
55. The anorectic and hypotensive effect of fenfluramine in obesity
56. Anorectic agents lower a body weight set point
57. Predicting the abuse liability of drugs with animal drug self‐administration procedures: Psychomotor stimulants and hallucinogens
58. Phenylpropanolamine as an anorexiant agent in weight control: A review of published and unpublished studies
59. Serotonin and appetite
60. Treatment of compulsive eating disturbances with anticonvulsant medication
61. Phenytoin treatment of the binge‐eating syndrome
62. Naloxone reduced food intake in humans
63. Naloxone decreases food intake in obese humans
64. A high dose naltrexone therapy and dietary counseling for obesity
65. Effects of long‐term therapy with naltrexone on body weight in obesity
66. Naltrexone and human eating behavior: A dose‐ranging inpatient trial in moderately obese men
67. A controlled trial of naltrexone in obese humans
68. Human chorionic gonadotrophin (HCG) in the treatment of obesity—a critical assessment of the Simeons method
69. Ineffectiveness of human chorionic gonadotrophin in weight reduction: A double‐blind study
70. Chorionic gonadotropin in weight control
71. Decrease in resting metabolic rate during rapid weight loss is reversed by low dose thyroid hormone treatment
72. The effects of triiodothyronine on energy expenditure, nitrogen balance and rates of weight and fat loss in obese patients during prolonged caloric restriction
73. Ephedrine as an anorectic: The story of the “Elsinore pill”
74. A controlled trial using ephedrine in the treatment of obesity
75. Does ephedrine promote weight loss in low‐energy‐adapted obese women?
76. Clinical studies with thermogenic drugs
77. Phenmetrazine hydrochloride and methylcellulose in the treatment of “refractory” obesity
78. Methylcellulose for obesity
79. Effect of a hydrophilic mucilage in the treatment of obese patients
80. Treatment of obesity with cholestyramine
81. Sucrose polyester: Substitution for dietary fats in hypocaloric diets in the treatment of familial hypercholesterolemia
82. The substitution of sucrose polyester for dietary fat in obese, hypercholesterolemic outpatients
83. Jaw wiring for weight reduction
84. Jaw wiring for obesity
85. Long‐term effects of jaw fixation in severe obesity
86. Maintenance of weight loss in obese patients after jaw wiring
87. Truncal vagotomy in morbid obesity
88. Body contouring by lipolysis: A 5‐year experience with over 3000 cases
89. The effectiveness of gastric bypass over gastric partition in morbid obesity
90. Guidelines for surgery for morbid obesity
91. Gastric bypass
92. Failure rate with gastric partitioning for morbid obesity
93. Comparative effectiveness of gastric bypass and gastroplasty
94. The surgical treatment of morbid obesity
95. Vertical ring gastroplasty for morbid obesity
96. Vertical gastroplasty for morbid obesity: Clinical experience
97. Late effects of gastric bypass for obesity
98. A review: Surgery for morbid obesity
99. Psychosocial effects of gastric reduction surgery for obesity
100. A prospective comparison of gastric and jejunoileal bypass procedures for morbid obesity
101. Comparisons between jejunoileal and gastric bypass operations for morbid obesity
102. Gastric and jejunoileal bypass. A comparison in the treatment of morbid obesity
103. Surgical concepts in the treatment of obesity
104. Partial and total biliopancreatic bypass in the surgical treatment of obesity
105. Long term treatment of severe obesity: Four year follow up of results of combined behavioural modification programme
106. Controlled trial of very low calorie diet, behavior therapy, and their combination in the treatment of obesity